Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cullinan To Search For Oncology’s Diamonds In The Rough

Executive Summary

With a business model based on portfolio management, the new company backed by MPM Capital plans to de-risk novel cancer therapies for out-licensing upon proof-of-concept or other value-creating inflection points.

Advertisement

Related Content

Deal Watch: Xencor Adds New Bispecific Partner In Agreement With Genentech
Start-Up Quarterly Statistics: 2017 Fundraising Ends Better Than It Began
Venture Funding Deals: From ADC To Y-mAbs, Capital Flows For New Platforms, Novel Approaches

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC099592

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel